1. Home
  2. ATLN vs ELTX Comparison

ATLN vs ELTX Comparison

Compare ATLN & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLN
  • ELTX
  • Stock Information
  • Founded
  • ATLN 2014
  • ELTX 2011
  • Country
  • ATLN United States
  • ELTX United States
  • Employees
  • ATLN N/A
  • ELTX N/A
  • Industry
  • ATLN
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATLN
  • ELTX Health Care
  • Exchange
  • ATLN NYSE
  • ELTX Nasdaq
  • Market Cap
  • ATLN 140.1M
  • ELTX 121.7M
  • IPO Year
  • ATLN 2021
  • ELTX N/A
  • Fundamental
  • Price
  • ATLN $2.17
  • ELTX $8.09
  • Analyst Decision
  • ATLN
  • ELTX Strong Buy
  • Analyst Count
  • ATLN 0
  • ELTX 2
  • Target Price
  • ATLN N/A
  • ELTX $9.50
  • AVG Volume (30 Days)
  • ATLN 69.6K
  • ELTX 48.3K
  • Earning Date
  • ATLN 08-22-2025
  • ELTX 08-12-2025
  • Dividend Yield
  • ATLN N/A
  • ELTX N/A
  • EPS Growth
  • ATLN N/A
  • ELTX N/A
  • EPS
  • ATLN N/A
  • ELTX N/A
  • Revenue
  • ATLN $444,795,409.00
  • ELTX N/A
  • Revenue This Year
  • ATLN N/A
  • ELTX N/A
  • Revenue Next Year
  • ATLN N/A
  • ELTX N/A
  • P/E Ratio
  • ATLN N/A
  • ELTX N/A
  • Revenue Growth
  • ATLN 10.11
  • ELTX N/A
  • 52 Week Low
  • ATLN $1.68
  • ELTX $3.70
  • 52 Week High
  • ATLN $7.97
  • ELTX $9.99
  • Technical
  • Relative Strength Index (RSI)
  • ATLN N/A
  • ELTX 62.14
  • Support Level
  • ATLN N/A
  • ELTX $7.76
  • Resistance Level
  • ATLN N/A
  • ELTX $8.94
  • Average True Range (ATR)
  • ATLN 0.00
  • ELTX 0.37
  • MACD
  • ATLN 0.00
  • ELTX -0.03
  • Stochastic Oscillator
  • ATLN 0.00
  • ELTX 51.09

About ATLN ATLANTIC INTERNATIONAL CORP

Atlantic International Corp is a U.S.-based outsourced services and workforce solutions company. The company specializes in permanent, temporary, and temporary-to-permanent placement services in various areas, including accounting and finance, administrative and clerical, hospitality, information technology, legal, light industrial, and medical fields. It also provides productivity consulting and workforce management solutions.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: